Core Insights - Bio-Techne Corporation will showcase its MauriceFlex™ System at the 72nd ASMS Conference, highlighting its capabilities in protein characterization and charge variant fractionation [1][4] - The MauriceFlex system simplifies the process of charge variant fraction collection, enhancing downstream protein characterization using various mass spectrometric methods [1][4] Product Features - The MauriceFlex system is an imaged capillary isoelectric focusing (icIEF) solution that supports icIEF-based fractionation and routine assays [1] - It enables the fractionation of charge isoforms in monoclonal antibodies and AAV capsid proteins, making it suitable for applications in cell and gene therapy [2][3] Conference Activities - A breakfast seminar titled "Solving the Challenges of Protein Charge Heterogeneity Characterization using icIEF" will be held on June 4th, featuring insights from Bio-Techne and the National Institute for Bioprocessing Research and Training [2] - Bio-Techne will present seven posters at the conference, detailing collaborations with industry partners like Pfizer and advancements in charge isoform characterization [3] Company Overview - Bio-Techne Corporation is a global life sciences company with over $1.1 billion in net sales for fiscal 2023 and approximately 3,100 employees [5] - The company provides innovative tools and bioactive reagents for research and clinical diagnostics, aiding in drug discovery and accurate clinical tests [5]
BIO-TECHNE TO HIGHLIGHT MULTIPLE APPLICATIONS OF THE MauriceFlex™ SYSTEM AT THE ANNUAL ASMS CONFERENCE